help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on May 5, 2005, doi:10.1164/rccm.200411-1486OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200411-1486OCv1
172/3/329    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Diemen, C. C.
Right arrow Articles by Boezen, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Diemen, C. C.
Right arrow Articles by Boezen, H. M.
American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 329-333, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200411-1486OC

Original Article

A Disintegrin and Metalloprotease 33 Polymorphisms and Lung Function Decline in the General Population

Cleo C. van Diemen, Dirkje S. Postma, Judith M. Vonk, Marcel Bruinenberg, Jan P. Schouten and H. Marike Boezen

Departments of Epidemiology and Bioinformatics, Pulmonology, and Medical Biology, University of Groningen, University Medical Center, Groningen, The Netherlands

Correspondence and requests for reprints should be addressed to H. Marike Boezen, Ph.D., UMCG, Department of Epidemiology and Bioinformatics, Room P1.129, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. E-mail: h.m.boezen{at}med.umcg.nl

Rationale: A disintegrin and metalloprotease 33 (ADAM33) has been identified as a susceptibility gene for asthma and single nucleotide polymorphisms (SNPs) in this gene have been associated with excessive decline of lung function in individuals with asthma. Objectives: To assess whether SNPs in ADAM33 are associated with accelerated lung function loss in the general population and with chronic obstructive pulmonary disease (COPD). Methods: DNA was collected from subjects of the Vlagtwedde–Vlaardingen cohort participating in the last survey in 1989–1990 after a follow-up of 25 years. Information was collected every 3 years, including lung function measurements. We defined COPD as GOLD stage 2 or higher at the last survey. A total of 1,390 subjects from the cohort was genotyped for the following SNPs in ADAM33: F+1, Q-1, S_1, S_2, T_1, T_2, V_4, and ST+5. Differences in prevalence of SNPs were analyzed with {chi}2 tests. Linear mixed effects models were used to analyze FEV1 decline according to genotype. Measurements and Main Results: In the whole population, mean adjusted decline was 18.7 and 12.7 ml/year in females and males, respectively. Individuals homozygous for minor alleles of SNPs S_2 and Q-1 and heterozygous for SNP S_1 had a significantly accelerated decline in FEV1 of, respectively, 4.9, 9.6, and 3.6 ml/year compared with wild type. We found a significantly higher prevalence of SNPs F+1, S_1, S_2, and T_2 in subjects with COPD. Conclusions: We demonstrated that SNPs in ADAM33 are associated with accelerated lung function decline in the general population. These SNPs are also risk factors for COPD.

Key Words: ADAM33 • chronic obstructive pulmonary disease • FEV1 • genetics • single nucleotide polymorphism




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Siedlinski, D. S. Postma, C. C. van Diemen, A. Blokstra, H. A. Smit, and H. M. Boezen
Lung Function Loss, Smoking, Vitamin C Intake, and Polymorphisms of the Glutamate-Cysteine Ligase Genes
Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 13 - 19.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M Siedlinski, C C van Diemen, D S Postma, and H M Boezen
Heme oxygenase 1 variations and lung function decline in smokers: proof of replication
J. Med. Genet., June 1, 2008; 45(6): 400 - 400.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Bush
Update in Pediatric Lung Disease 2007
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 686 - 695.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
T. R. Bai, J. M. Vonk, D. S. Postma, and H. M. Boezen
Severe exacerbations predict excess lung function decline in asthma
Eur. Respir. J., September 1, 2007; 30(3): 452 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. M. Lloyd and D. S. Robinson
Allergen-induced airway remodelling
Eur. Respir. J., May 1, 2007; 29(5): 1020 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
F. Sampsonas, A. Kaparianos, D. Lykouras, K. Karkoulias, and K. Spiropoulos
DNA sequence variations of metalloproteinases: their role in asthma and COPD
Postgrad. Med. J., April 1, 2007; 83(978): 244 - 250.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M. M E Gosman, H Marike Boezen, C. C van Diemen, J. B Snoeck-Stroband, T. S Lapperre, P. S Hiemstra, N. H T ten Hacken, J. Stolk, D. S Postma, and the GLUCOLD Study Group
A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology
Thorax, March 1, 2007; 62(3): 242 - 247.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
H. M. Boezen and D. S. Postma
Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression?
Eur. Respir. J., January 1, 2007; 29(1): 8 - 10.
[Full Text] [PDF]

Home page
 ERRHome page
CleoC. van Diemen, DirkjeS. Postma, JudithM. Vonk, M. Bruinenberg, JanP. Schouten, and H. Marike Boezen
A Disintegrin and Metalloprotease 33 polymorphisms and lung function decline in the general population
Eur. Respir. Rev., December 1, 2006; 15(101): 204 - 206.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Kraft
Asthma and chronic obstructive pulmonary disease exhibit common origins in any country!
Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 238 - 240.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. J. Barnes
Against the dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases.
Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 240 - 243.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. T. Holgate, Y. Yang, H.-M. Haitchi, R. M. Powell, J. W. Holloway, H. Yoshisue, Y. Y. Pang, J. Cakebread, and D. E. Davies
The Genetics of Asthma: ADAM33 as an Example of a Susceptibility Gene.
Proceedings of the ATS, July 1, 2006; 3(5): 440 - 443.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 698 - 706.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J.-Y. Lee, S.-W. Park, H. K. Chang, H. Y. Kim, T. Rhim, J.-H. Lee, A.-S. Jang, E.-S. Koh, and C.-S. Park
A Disintegrin and Metalloproteinase 33 Protein in Patients with Asthma: Relevance to Airflow Limitation
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 729 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. Boxall, S. T. Holgate, and D. E. Davies
The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma
Eur. Respir. J., January 1, 2006; 27(1): 208 - 229.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
Spoken sessions
Thorax, December 1, 2005; 60(suppl_2): ii4 - ii52.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society 		  ATS State of the Art 2009